David Hoang

Stock Analyst at Deutsche Bank

(0)
# 4666
Out of 5,370 analysts
44
Total ratings
42.31%
Success rate
-14.86%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
ACAD ACADIA Pharmaceutica...
Upgrades: Buy
20 35
22.12 58.23% 5 May 21, 2025
ALKS Alkermes
Maintains: Strong Buy
40 52
29.41 76.81% 2 Mar 27, 2025
SRPT Sarepta Therapeutics
Maintains: Hold
124 99
20.99 371.65% 6 Mar 19, 2025
XENE Xenon Pharmaceutical...
Initiates Coverage On: Buy
67
32.07 108.92% 3 Feb 11, 2025
PRAX Praxis Precision Med...
Initiates Coverage On: Buy
111
43.77 153.6% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
55
32.94 66.97% 2 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
31
14.59 112.47% 3 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
65
15.15 329.04% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
176
101.88 72.75% 4 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
9.48 26.58% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
150 158
125.3 26.1% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
45 50
n/a n/a 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
1.14 514.04% 1 Jul 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
8
9.06 -11.7% 1 May 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
5.05 216.83% 1 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
3.31 383.38% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
220
308.78 -28.75% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
80
15.66 410.86% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 25
n/a n/a 1 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3
1.28 134.38% 1 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 1, 2022